Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
The American Journal of Pathology|May 1, 2025
Collagen VII Is Associated with Airway Remodeling, Honeycombing, and Fibroblast Foci in Usual Interstitial Pneumonia/Idiopathic Pulmonary FibrosisBarbora Svobodová, Anna Löfdahl, Måns Kadefors, et al.International Journal of Molecular Sciences|January 9, 2021
Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial MigrationMariam Bagher, Oskar Rosmark, Linda Elowsson Rendin, et al.Cancer Letters|May 15, 2022
Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expressionNatalie Walterskirchen, Catharina Müller, Cristiano Ramos, et al.Cancer Letters|March 28, 2025
Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different originVasileios Gerakopoulos, Cristiano Ramos, Catharina Müller, et al.Development (Cambridge, England)|February 25, 2010
SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossificationTakako Hattori, Catharina Müller, Sonja Gebhard, et al.The American Journal of Pathology|June 10, 2021
Protein Signatures of Remodeled Airways in Transplanted Lungs with Bronchiolitis Obliterans Syndrome Obtained Using Laser-Capture MicrodissectionCatharina Müller, Oskar Rosmark, Emma Åhrman, et al.Oncotarget|July 3, 2018
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literatureAndrea Kuendgen, Catharina Müller-Thomas, Michael Lauseker, et al.International Journal of Molecular Sciences|August 21, 2019
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary FibrosisLinda Elowsson Rendin, Anna Löfdahl, Emma Åhrman, et al.Hemasphere|September 24, 2024
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDSPaolo Mazzeo, Christina Ganster, John Wiedenhöft, et al.Oncotarget|May 1, 2018
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profileVeronika Reidel, Johanna Kauschinger, Richard T Hauch, et al.Pageof 5